ACCEPT SIMS AI™

AI-enabled screening intelligence and navigation

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
777
Screening encounters
781
Diagnostic referrals
140
Outstanding pathways
90

Screening pathway

  1. Screening781Encounters
  2. Positive finding254Documented findings
  3. Referral140Diagnostic referrals
  4. Follow-up115Diagnostic visits
  5. Outcome50Resolved pathways

Stage totals use different units. Pending pathways: 90. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 3003 · EXP-3003Synthetic · Site C

Full participant history through 2025-05-21, across modalities and pathways.

  1. · Screening · HPV DNA · Initial · Programme entry
  2. · Screening result · HPV DNA · HPV not detected · Adequate

Referral-time risk

No matching referral was available at this observation date.

Screened participants

777 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-3003 · Expanded synthetic participant 3003Site C — Rural Outreach Programme
EXP-3006 · Expanded synthetic participant 3006Site C — Rural Outreach Programme
EXP-3018 · Expanded synthetic participant 3018Site B — Peri-Urban Access Programme
EXP-3027 · Expanded synthetic participant 3027Site C — Rural Outreach Programme
EXP-3029 · Expanded synthetic participant 3029Site D — Community Engagement Programme
EXP-3033 · Expanded synthetic participant 3033Site C — Rural Outreach Programme
EXP-3035 · Expanded synthetic participant 3035Site A — Urban Referral Hub
EXP-3044 · Expanded synthetic participant 3044Site D — Community Engagement Programme
EXP-3049 · Expanded synthetic participant 3049Site D — Community Engagement Programme
EXP-3053 · Expanded synthetic participant 3053Site D — Community Engagement Programme
EXP-3054 · Expanded synthetic participant 3054Site C — Rural Outreach Programme
EXP-3063 · Expanded synthetic participant 3063Site E — Resource-Constrained Navigation Programme
EXP-3071 · Expanded synthetic participant 3071Site D — Community Engagement Programme
EXP-3074 · Expanded synthetic participant 3074Site D — Community Engagement Programme
EXP-3079 · Expanded synthetic participant 3079Site A — Urban Referral Hub
EXP-3081 · Expanded synthetic participant 3081Site A — Urban Referral Hub
EXP-3090 · Expanded synthetic participant 3090Site D — Community Engagement Programme
EXP-3101 · Expanded synthetic participant 3101Site A — Urban Referral Hub
EXP-3104 · Expanded synthetic participant 3104Site C — Rural Outreach Programme
EXP-3105 · Expanded synthetic participant 3105Site B — Peri-Urban Access Programme
EXP-3106 · Expanded synthetic participant 3106Site B — Peri-Urban Access Programme
EXP-3122 · Expanded synthetic participant 3122Site B — Peri-Urban Access Programme
EXP-3129 · Expanded synthetic participant 3129Site C — Rural Outreach Programme
EXP-3131 · Expanded synthetic participant 3131Site D — Community Engagement Programme
EXP-3141 · Expanded synthetic participant 3141Site E — Resource-Constrained Navigation Programme

Programme insights

Encounters by modality

VIA
356
HPV DNA
312
Cytology
113

Navigation activity

Barrier documented
95
Contact attempt
195
Navigation intervention
39
Diagnostic booking
159
Diagnostic visit
115

Documented barriers

Contact difficulty
27
Transport difficulty
33
Appointment coordination
35

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.